BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22948360)

  • 21. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
    Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency of TRDMT1 impairs exogenous RNA-based response and promotes retrotransposon activity during long-term culture of osteosarcoma cells.
    Betlej G; Lewińska A; Adamczyk-Grochala J; Błoniarz D; Rzeszutek I; Wnuk M
    Toxicol In Vitro; 2022 Apr; 80():105323. PubMed ID: 35104602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling.
    Lu Y; Li F; Xu T; Sun J
    Int J Mol Med; 2017 Apr; 39(4):993-1000. PubMed ID: 28260091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
    Gaspar N; Venkatramani R; Hecker-Nolting S; Melcon SG; Locatelli F; Bautista F; Longhi A; Lervat C; Entz-Werle N; Casanova M; Aerts I; Strauss SJ; Thebaud E; Morland B; Nieto AC; Marec-Berard P; Gambart M; Rossig C; Okpara CE; He C; Dutta L; Campbell-Hewson Q
    Lancet Oncol; 2021 Sep; 22(9):1312-1321. PubMed ID: 34416158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models.
    Ferreira de Oliveira JMP; Pacheco AR; Coutinho L; Oliveira H; Pinho S; Almeida L; Fernandes E; Santos C
    Arch Toxicol; 2018 Mar; 92(3):1205-1214. PubMed ID: 29270805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nudol, a phenanthrene derivative from
    Zhang Y; Zhang Q; Xin W; Liu N; Zhang H
    Drug Des Devel Ther; 2019; 13():2591-2601. PubMed ID: 31551653
    [No Abstract]   [Full Text] [Related]  

  • 27. Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.
    Holt SV; Brookes KE; Dive C; Makin GW
    Oncol Rep; 2011 Apr; 25(4):1177-81. PubMed ID: 21286665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive cytotoxic effect of apoptin and chemotherapeutic agents paclitaxel and etoposide on human tumour cells.
    Olijslagers SJ; Zhang YH; Backendorf C; Noteborn MH
    Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):127-31. PubMed ID: 17244262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo.
    Lin CC; Chuang YJ; Yu CC; Yang JS; Lu CC; Chiang JH; Lin JP; Tang NY; Huang AC; Chung JG
    J Agric Food Chem; 2012 Nov; 60(45):11395-402. PubMed ID: 23066961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma.
    Coutinho L; Oliveira H; Pacheco AR; Almeida L; Pimentel F; Santos C; Ferreira de Oliveira JM
    DNA Repair (Amst); 2017 Feb; 50():36-42. PubMed ID: 28063664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.
    Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR
    Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.
    Kamata E; Kawamoto T; Ueha T; Hara H; Fukase N; Minoda M; Morishita M; Takemori T; Fujiwara S; Nishida K; Kuroda R; Kurosaka M; Akisue T
    Anticancer Res; 2017 Nov; 37(11):6097-6106. PubMed ID: 29061790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic effects of delphinidin in human osteosarcoma cells.
    Lee DY; Park YJ; Hwang SC; Kim KD; Moon DK; Kim DH
    Acta Orthop Traumatol Turc; 2018 Jan; 52(1):58-64. PubMed ID: 29290536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
    Fujimoto S; Chikazawa H
    Jpn J Cancer Res; 1998 Dec; 89(12):1343-51. PubMed ID: 10081496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (U-2 OS).
    Lu KH; Lue KH; Chou MC; Chung JG
    J Orthop Res; 2005 Sep; 23(5):988-94. PubMed ID: 16140185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.